Hannes Hagström
Hannes Hagström
Verifierad e-postadress på ki.se
TitelCiteras avÅr
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
M Ekstedt, H Hagström, P Nasr, M Fredrikson, P Stål, S Kechagias, ...
Hepatology 61 (5), 1547-1554, 2015
7752015
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis
PS Dulai, S Singh, J Patel, M Soni, LJ Prokop, Z Younossi, G Sebastiani, ...
Hepatology 65 (5), 1557-1565, 2017
2832017
Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis
G Musso, R Gambino, JH Tabibian, M Ekstedt, S Kechagias, ...
PLoS medicine 11 (7), e1001680, 2014
2472014
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
H Hagström, P Nasr, M Ekstedt, U Hammar, P Stål, R Hultcrantz, ...
Journal of hepatology 67 (6), 1265-1273, 2017
1342017
Efficacy and safety of mycophenolate mofetil and tacrolimus as second-line therapy for patients with autoimmune hepatitis
C Efe, H Hagström, H Ytting, RA Bhanji, NF Müller, Q Wang, T Purnak, ...
Clinical Gastroenterology and Hepatology 15 (12), 1950-1956. e1, 2017
382017
Overweight in late adolescence predicts development of severe liver disease later in life: a 39 years follow-up study
H Hagström, P Stål, R Hultcrantz, T Hemmingsson, A Andreasson
Journal of hepatology 65 (2), 363-368, 2016
332016
Adverse outcomes of pregnancy in women with non‐alcoholic fatty liver disease
H Hagström, J Höijer, JF Ludvigsson, M Bottai, A Ekbom, R Hultcrantz, ...
Liver International 36 (2), 268-274, 2016
292016
High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men
H Hagström, P Tynelius, F Rasmussen
Gut 67 (8), 1536-1542, 2018
262018
Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease
H Hagström, P Nasr, M Ekstedt, S Kechagias, K Önnerhag, E Nilsson, ...
Scandinavian journal of gastroenterology 52 (2), 159-165, 2017
232017
Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long‐term follow‐up study
H Hagström, P Nasr, M Ekstedt, U Hammar, P Stål, R Hultcrantz, ...
Hepatology communications 2 (1), 48-57, 2018
202018
Elevated serum ferritin is associated with increased mortality in non‐alcoholic fatty liver disease after 16 years of follow‐up
H Hagström, P Nasr, M Bottai, M Ekstedt, S Kechagias, R Hultcrantz, ...
Liver International 36 (11), 1688-1695, 2016
172016
SAF score and mortality in NAFLD after up to 41 years of follow-up
H Hagström, P Nasr, M Ekstedt, S Kechagias, P Stål, P Bedossa, ...
Scandinavian journal of gastroenterology 52 (1), 87-91, 2017
162017
Alcohol consumption in patients with primary sclerosing cholangitis
H Hagström, P Stål, K Stokkeland, A Bergquist
World journal of gastroenterology: WJG 18 (24), 3105, 2012
162012
Alcohol consumption in concomitant liver disease: how much is too much?
H Hagström
Current hepatology reports 16 (2), 152-157, 2017
142017
Alcohol consumption in late adolescence is associated with an increased risk of severe liver disease later in life
H Hagström, T Hemmingsson, A Discacciati, A Andreasson
Journal of hepatology 68 (3), 505-510, 2018
122018
Waist/hip ratio better predicts development of severe liver disease within 20 years than body mass index: a population-based cohort study
A Andreasson, AC Carlsson, K Önnerhag, H Hagström
Clinical Gastroenterology and Hepatology 15 (8), 1294-1301. e2, 2017
122017
Cardiovascular risk factors in non‐alcoholic fatty liver disease
H Hagström, P Nasr, M Ekstedt, U Hammar, P Stål, J Askling, R Hultcrantz, ...
Liver International 39 (1), 197-204, 2019
102019
Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries
M Holmer, E Melum, H Isoniemi, BG Ericzon, M Castedal, A Nordin, ...
Liver International 38 (11), 2082-2090, 2018
102018
Development of serum marker models to increase diagnostic accuracy of advanced fibrosis in nonalcoholic fatty liver disease: the new LINKI algorithm compared with established …
B Lykiardopoulos, H Hagström, M Fredrikson, S Ignatova, P Stål, ...
PloS one 11 (12), e0167776, 2016
92016
Alcohol, smoking and the liver disease patient
H Hagström
Best Practice & Research Clinical Gastroenterology 31 (5), 537-543, 2017
72017
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20